
The Current Evidence for Lipid Management in Patients with Lower Extremity Peripheral Artery Disease: What Is the Therapeutic Target?
PURPOSE OF REVIEW: There is a lack of consistency among the ACC/AHA and ESC Guidelines on the treatment of patients with lower extremity PAD to a targeted LDL-c level. A review of the current guidelines, as well as the evidence that exists for use of various lipid-lower therapies in patients with PAD, is needed to guide clinical practice and to examine the current gaps in evidence that exist. RECENT FINDINGS: There is evidence that statins and PCSK9 inhibitors reduce the risks of major adverse cardiovascular and limb events in patients with PAD. Most statin and non-statin trials have examined the association of LLT use with clinical outcomes, and not the association between the degree of LDL-c lowering and the reduction in risk of clinical outcomes. As such, there is a lack of agreement between the American and European PAD Guidelines over whether to treat patients with PAD to a targeted LDL-c goal. Both statins and PCSK9 inhibitors have been shown to reduce the risk of major cardiovascular and limb events in patients with PAD. Further research is needed to determine if target driven LDL-c lowering is associated with improved outcomes in patients with PAD.
Duke Scholars
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Proprotein Convertase 9
- Peripheral Arterial Disease
- Lower Extremity
- Lipids
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Anticholesteremic Agents
- 3201 Cardiovascular medicine and haematology
Citation

Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Proprotein Convertase 9
- Peripheral Arterial Disease
- Lower Extremity
- Lipids
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Anticholesteremic Agents
- 3201 Cardiovascular medicine and haematology